Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2681 |
|
Actual shortage: | 255 (10%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2417 (90%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
23 (9%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-PRAZOSIN | 5MG | TABLET | Resolved | 2022-02-10 | 2022-03-24 | 154729 |
TEVA-HALOPERIDOL | 5MG | TABLET | Resolved | 2022-03-10 | 2023-05-23 | 156415 |
TEVA-RAMIPRIL | 5MG | CAPSULE | Resolved | 2022-04-21 | 2022-08-20 | 159210 |
TEVA-AMPHETAMINE XR | 5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2022-05-12 | 2022-07-01 | 160420 |
TEVA-TEMOZOLOMIDE | 5MG | CAPSULE | Resolved | 2022-06-09 | 2022-09-23 | 162268 |
TEVA-SOLIFENACIN | 5MG | TABLET | Resolved | 2022-06-09 | 2022-08-09 | 162300 |
TEVA-OLANZAPINE | 5MG | TABLET | Resolved | 2022-06-30 | 2022-08-20 | 163933 |
TEVA-RISEDRONATE | 5MG | TABLET | Resolved | 2022-06-30 | 2022-12-08 | 163948 |
TEVA-MONTELUKAST | 5MG | TABLET (CHEWABLE) | Resolved | 2022-06-30 | 2022-10-18 | 163951 |
TEVA-OLANZAPINE | 5MG | TABLET | Resolved | 2022-09-22 | 2022-10-01 | 169948 |
TEVA-RIZATRIPTAN ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2022-09-22 | 2023-04-28 | 169983 |
TEVA-PREDNISONE | 5MG | TABLET | Resolved | 2022-12-01 | 2023-01-19 | 176761 |
TEVA-PRAZOSIN | 5MG | TABLET | Actual shortage | 2022-12-01 | 2023-12-21 | 176806 |
ACT AMLODIPINE | 5MG | TABLET | Resolved | 2022-12-15 | 2023-02-16 | 178518 |
TEVA-BISOPROLOL | 5MG | TABLET | Resolved | 2022-12-22 | 2023-01-19 | 179300 |
TEVA-ZOPICLONE | 5MG | TABLET | Actual shortage | 2023-02-02 | 2024-02-01 | 183386 |
TEVA-OLANZAPINE | 5MG | TABLET | Resolved | 2023-02-02 | 2023-04-28 | 183389 |
ACT AMLODIPINE | 5MG | TABLET | Resolved | 2023-02-09 | 2023-04-28 | 184204 |
TEVA-FINASTERIDE | 5MG | TABLET | Resolved | 2023-02-09 | 2023-04-28 | 184210 |
TEVA-AMPHETAMINE XR | 5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2023-02-09 | 2023-07-28 | 184219 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81337 | ||
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81344 | ||
HYDROCORTISONE SODIUM SUCCINATE INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81347 | ||
TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106136 | ||
TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106139 | ||
RATIO-SALBUTAMOL | Discontinued | 2020-02-13 | 2020-02-13 | 106151 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106155 | ||
EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106170 | ||
LINEZOLID INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106173 | ||
EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106176 |